Modjtaba Emadi‐Baygi

1.1k total citations
52 papers, 931 citations indexed

About

Modjtaba Emadi‐Baygi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Modjtaba Emadi‐Baygi has authored 52 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Modjtaba Emadi‐Baygi's work include Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Cancer Cells and Metastasis (6 papers). Modjtaba Emadi‐Baygi is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), RNA modifications and cancer (8 papers) and Cancer Cells and Metastasis (6 papers). Modjtaba Emadi‐Baygi collaborates with scholars based in Iran, Germany and United States. Modjtaba Emadi‐Baygi's co-authors include Parvaneh Nikpour, Wolfgang A. Schulz, Zahra‐Soheila Soheili, Mohsen Taghizadeh, Mohammad Reza Memarzadeh, Parvaneh Jafari, Batool Zamani, Maryam Ebrahimi, Zatollah Asemi and Kamran Ghaedi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience and Frontiers in Immunology.

In The Last Decade

Modjtaba Emadi‐Baygi

50 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Modjtaba Emadi‐Baygi Iran 15 616 284 144 143 86 52 931
Sang‐Ho Kwon United States 19 582 0.9× 194 0.7× 57 0.4× 50 0.3× 72 0.8× 44 884
Gang Hu China 14 448 0.7× 143 0.5× 50 0.3× 245 1.7× 46 0.5× 40 851
Shanwen Chen China 20 585 0.9× 347 1.2× 47 0.3× 205 1.4× 54 0.6× 36 993
Sadeesh K. Ramakrishnan United States 15 353 0.6× 159 0.6× 132 0.9× 77 0.5× 79 0.9× 22 843
C. Fernández-López Spain 15 469 0.8× 290 1.0× 84 0.6× 54 0.4× 48 0.6× 33 978
Natalya V. Guseva United States 18 509 0.8× 186 0.7× 46 0.3× 131 0.9× 54 0.6× 37 764
Abas H. Laftah United Kingdom 12 493 0.8× 173 0.6× 82 0.6× 63 0.4× 37 0.4× 21 1.4k
Jing Xiong China 19 538 0.9× 298 1.0× 77 0.5× 93 0.7× 37 0.4× 48 918
Fons K. Verheyen Netherlands 14 380 0.6× 74 0.3× 189 1.3× 78 0.5× 55 0.6× 17 902

Countries citing papers authored by Modjtaba Emadi‐Baygi

Since Specialization
Citations

This map shows the geographic impact of Modjtaba Emadi‐Baygi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Modjtaba Emadi‐Baygi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Modjtaba Emadi‐Baygi more than expected).

Fields of papers citing papers by Modjtaba Emadi‐Baygi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Modjtaba Emadi‐Baygi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Modjtaba Emadi‐Baygi. The network helps show where Modjtaba Emadi‐Baygi may publish in the future.

Co-authorship network of co-authors of Modjtaba Emadi‐Baygi

This figure shows the co-authorship network connecting the top 25 collaborators of Modjtaba Emadi‐Baygi. A scholar is included among the top collaborators of Modjtaba Emadi‐Baygi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Modjtaba Emadi‐Baygi. Modjtaba Emadi‐Baygi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emadi‐Baygi, Modjtaba, et al.. (2021). A Metabolic Model of Intestinal Secretions: The Link between Human Microbiota and Colorectal Cancer Progression. Metabolites. 11(7). 456–456. 13 indexed citations
3.
Eshghi, Mohammad, et al.. (2020). Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers. Biotechnology Letters. 42(8). 1419–1429. 10 indexed citations
5.
Emadi‐Baygi, Modjtaba, et al.. (2016). In silico analysis of deleterious single nucleotide polymorphisms in human BUB1 mitotic checkpoint serine/threonine kinase B gene. Meta Gene. 9. 142–150. 9 indexed citations
7.
Nikpour, Parvaneh, et al.. (2015). Comparison of TaqMan Real-Time and Tetra-Primer ARMS PCR Techniques for Genotyping of Rs 8066560 Variant in Children and Adolescents with Metabolic Syndrome. Advances in Clinical and Experimental Medicine. 24(6). 951–955. 1 indexed citations
8.
Kheirollahi, Majid, et al.. (2015). Expression of ZFX gene correlated with the central features of the neoplastic phenotype in human brain tumors with distinct phenotypes. Advanced Biomedical Research. 4(1). 179–179. 4 indexed citations
9.
Emadi‐Baygi, Modjtaba, et al.. (2014). Absence of Association between -1131T>C Polymorphism in the Apolipoprotein APOA5 Gene and Pediatric Metabolic Syndrome.. Europe PMC (PubMed Central). 24(3). 319–22. 4 indexed citations
10.
Nikpour, Parvaneh, et al.. (2014). Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis. SHILAP Revista de lepidopterología. 3(1). 135–135. 31 indexed citations
11.
Emadi‐Baygi, Modjtaba, et al.. (2014). MTDH/AEG-1 contributes to central features of the neoplastic phenotype in bladder cancer. Urologic Oncology Seminars and Original Investigations. 32(5). 670–677. 16 indexed citations
12.
Nikpour, Parvaneh, et al.. (2013). The G395R Mutation of the Sodium/Iodide Symporter (NIS) Gene in Patients with Dyshormonogenetic Congenital Hypothyroidism. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Emadi‐Baygi, Modjtaba & Parvaneh Nikpour. (2012). Deregulation of MTDH Gene Expression in Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 13(6). 2833–2836. 13 indexed citations
14.
Nikpour, Parvaneh, et al.. (2012). MSI1 overexpression in diffuse type of gastric cancer. Pathology - Research and Practice. 209(1). 10–13. 14 indexed citations
15.
Ghaedi, Kamran, Ahmad Salamian, Khadije Karbalaie, et al.. (2012). Fndc5 knockdown significantly decreased neural differentiation rate of mouse embryonic stem cells. Neuroscience. 231. 296–304. 128 indexed citations
16.
Nikpour, Parvaneh, et al.. (2012). Differential expression of ZFX gene in gastric cancer. Journal of Biosciences. 37(1). 85–90. 31 indexed citations
17.
Nikpour, Parvaneh, Modjtaba Emadi‐Baygi, Christine Steinhoff, et al.. (2010). The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. Journal of Cellular and Molecular Medicine. 15(5). 1210–1224. 51 indexed citations
18.
Emadi‐Baygi, Modjtaba, Zahra‐Soheila Soheili, Frank Eßmann, et al.. (2010). Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. Tumor Biology. 31(4). 297–307. 74 indexed citations
19.
Babaei, Esmaeil, et al.. (2006). Detection of Survivin Gene Expression in Formalin-Fixed Paraffin-Embedded Tissues of Human Osteosarcoma: Its Potential Usefulness in Diagnosis and Prognosis of Bone Tumors. 10(1). 39–45. 6 indexed citations
20.
Emadi‐Baygi, Modjtaba, et al.. (2005). Evaluation of sensitivity and specificity of urine survivin as a new molecular marker in diagnosis of bladder tumors. Iranian Journal of Biotechnology. 3(3). 163–169. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026